The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC)
Top Cited Papers
- 12 January 2012
- journal article
- review article
- Published by Elsevier BV in Seminars in Cancer Biology
- Vol. 22 (2), 144-153
- https://doi.org/10.1016/j.semcancer.2012.01.004
Abstract
No abstract availableKeywords
This publication has 144 references indexed in Scilit:
- Epstein-Barr Virus latent membrane protein 1 induces Snail and epithelial–mesenchymal transition in metastatic nasopharyngeal carcinomaBritish Journal of Cancer, 2011
- MicroRNA-10b induced by Epstein-Barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cellsCancer Letters, 2010
- Epstein-Barr virus latent membrane protein-2A-induced ΔNp63α expression is associated with impaired epithelial-cell differentiationOncogene, 2010
- The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradationOncogene, 2009
- MicroRNA deregulation and pathway alterations in nasopharyngeal carcinomaBritish Journal of Cancer, 2009
- The c-Cbl proto-oncoprotein downregulates EBV LMP2A signalingVirology, 2009
- The ID proteins contribute to the growth of rodent fibroblasts during LMP1-mediated transformationVirology, 2008
- An auto-regulatory loop for EBV LMP2A involves activation of NotchVirology, 2008
- Cholesterol is critical for Epstein-Barr virus latent membrane protein 2A trafficking and protein stabilityVirology, 2007
- High level expression of ΔN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?Oncogene, 2000